American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 4.
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. karen.walker@thomson.com
Karen
K
Walker
Alexandra
A
Kibble
Jaya
J
Shumoogam
D018943:Anthracyclines / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D035843:Biomedical Research / Q000379:methods / Q000639:trends; D018394:CA-125 Antigen / Q000032:analysis; D002986:Clinical Trials as Topic; D000069439:Dasatinib; D005260:Female; D006801:Humans; D007191:Indazoles; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D015394:Molecular Structure; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011743:Pyrimidines / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D012910:Snake Venoms / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D013844:Thiazoles / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D016896:Treatment Outcome
D018943:Anthracyclines; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D007191:Indazoles; D011743:Pyrimidines; D012910:Snake Venoms; D013449:Sulfonamides; D013844:Thiazoles; C451735:WP 744; C422910:Cilengitide; C516667:pazopanib; D000069439:Dasatinib